Screened after invitation1 | Routine opportunistic testing2 | Sporadic opportunistic testing3 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
n/N4 | % | n/N5 | % | PPD % (95 % CI)6 | PPR (95 % CI)7 | n/N8 | % | PPD % (95 % CI)9 | PPR (95 % CI)10 | |
Cytological diagnosis | ||||||||||
Normal cells | ||||||||||
23-28 | 92,693/104,448 | (88.7) | 32,034/36,357 | (88.1) | -0.6 (-1.0;-0.2) | 0.99 (0.98;1.00) | 9,141/10,417 | (87.8) | -0.6 (-1.6;-0.2) | 0.99 (0.98;1.00) |
29-34 | 87,023/93,912 | (92.7) | 33,615/36,896 | (91.1) | -1.6 (-2.0;-1.2) | 0.98 (0.98;1.00) | 11,887/13,004 | (91.4) | -1.3 (-1.8;-0.8) | 0.99 (0.98;1.00) |
35-42 | 149,489/158,989 | (94.0) | 40,764/44,098 | (92.4) | -1.6 (-1.9;-1.3) | 0.98 (0.98;0.99) | 16,960/18,280 | (92.8) | -1.2 (-1.6;-0.8) | 0.99 (0.98;0.99) |
43-49 | 149,650/157,444 | (95.0) | 30,384/32,427 | (93.7) | -1.3 (-1.6;-1.0) | 0.99 (0.98;0.99) | 15,878/16,889 | (94.0) | -1.0 (-1.4;-0.6) | 0.98 (0.99;1.00) |
HSIL | ||||||||||
23-28 | 1,762/104,448 | (1.7) | 778/36,357 | (2.1) | 0.4 (-0.8;1.6) | 1.27 (1.17;1.38) | 156/10,417 | (1.5) | -0.2 (-2.2;1.8) | 0.89 (0.75;1.04) |
29-34 | 1,217/93,912 | (1.3) | 631/36,896 | (1.7) | 0.4 (-0.8;1.6) | 1.26 (1.15;1.39) | 105/13,004 | (0.8) | -0.5 (-0.2;1.3) | 0.59 (0.49;0.73) |
35-42 | 1,242/158,989 | (0.8) | 552/44,098 | (1.3) | 0.5 (-0.6;1.6) | 1.60 (1.45;1.77) | 89/18,280 | (0.5) | -0.3 (-1.8;1.2) | 0.62 (0.50;0.77) |
43-49 | 570/157,444 | (0.4) | 267/32,427 | (0.8) | 0.4 (-0.8;1.6) | 2.27 (1.97;2.63) | 58/16,889 | (0.3) | -0.1 (-1.6;1.4) | 0.95 (0.72;1.24) |
Carcinoma in situ + AIS | ||||||||||
23-28 | 22/104,448 | (0.02) | 8/36,357 | (0.02) | 0.0 (-1.4;1.4) | 1.05 (0.47;2.35) | 2/10,417 | (0.02) | 0.0 (-2.0;2.0) | 0.91 (0.21;3.88) |
29-34 | 30/93,912 | (0.03) | 19/36,896 | (0.05) | 0.02 (-1.2;1.2) | 1.61 (0.91;2.86) | 5/13,004 | (0.04) | 0.01 (-1.8;1.9) | 1.20 (0.47;3.10) |
35-42 | 37/158,989 | (0.02) | 15/44,098 | (0.03) | 0.01 (-0.9;0.9) | 1.46 (0.80;2.66) | 6/18,280 | (0.03) | 0.01 (-1.4;1.4) | 1.41 (0.60;3.34) |
43-49 | 17/157,444 | (0.01) | 3/32,427 | (0.01) | 0.0 (-1.2;1.2) | 0.86 (0.25;2.92) | 1/16,889 | (0.01) | NA | 0.55 (0.07;4.12) |
Carcinoma11 | ||||||||||
23-28 | 4/104,448 | (0.00) | 3/36,357 | (0.01) | 0.01 (-1.1;1.1) | 2.16 (0.48;9.63) | 1/10,417 | (0.01) | NA | 2.51 (0.28;22.4) |
29-34 | 9/93,912 | (0.01) | 6/36,896 | (0.02) | 0.01 (-1.2;1.3) | 1.70 (0.60;4.77) | 0/13,004 | (0.00) | NA | NA |
35-42 | 17/158,989 | (0.01) | 20/44,098 | (0.05) | 0.04 (-1.0;1.1) | 4.18 (2.19;7.99) | 0/18,280 | (0.00) | NA | NA |
43-49 | 12/157,444 | (0.01) | 13/32,427 | (0.04) | 0.03 (-1.2;1.3) | 5.26 (2.40;11.5) | 1/16,889 | (0.01) | NA | 0.78 (0.10;5.97) |